Skip to content

Drug interactions

Ribociclib + Rucaparib

Severity: Minor

Ribociclib and Rucaparib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rucaparib is a weak inhibitor of CYP3A4 in vitro and clinically, and ribociclib is a CYP3A4 substrate. Ribociclib exposure may rise slightly, which could add to QT prolongation and neutropenia. The effect is expected to be modest.

What this interaction means in plain words

Ribociclib and Rucaparib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ribociclib belongs to Oncology; Rucaparib belongs to Oncology.

Evidence level: Low

Why it happens

Weak inhibition of CYP3A4-mediated ribociclib metabolism by rucaparib.

What to do

No empirical dose change is needed. Monitor ECG, electrolytes and blood counts as already required for ribociclib.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ribociclib and Rucaparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ribociclib with Rucaparib?

MediHelp rates the interaction as minor. Ribociclib and Rucaparib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Rucaparib is a weak inhibitor of CYP3A4 in vitro and clinically, and ribociclib is a CYP3A4 substrate. Ribociclib exposure may rise slightly, which could add to QT prolongation and neutropenia. The effect is expected to be modest.

How serious is the interaction between Ribociclib and Rucaparib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empirical dose change is needed. Monitor ECG, electrolytes and blood counts as already required for ribociclib.

What other medicines interact with Ribociclib?

MediHelp also lists interactions of Ribociclib with, for example, Amiodarone, Cisapride, Dofetilide. The full list is on the Ribociclib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in